NFKB1 and Alzheimer disease: A case–control clinical study recently published by us [24] evidenced in whole blood nine inflammation and seven redox genes that discriminate very well between mild AD patients and controls, resulting from the increased activity of NFκB, NRF2 and several zinc finger and helix-loop-helix transcription factors.